|
PSME3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.245000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.807000E-01 |
| Normal-vs-Stage2 |
5.413600E-01 |
| Normal-vs-Stage3 |
7.243600E-01 |
| Normal-vs-Stage4 |
8.948600E-01 |
| Stage1-vs-Stage2 |
5.703000E-01 |
| Stage1-vs-Stage3 |
7.791200E-01 |
| Stage1-vs-Stage4 |
8.994600E-01 |
| Stage2-vs-Stage3 |
8.032600E-01 |
| Stage2-vs-Stage4 |
6.254200E-01 |
| Stage3-vs-Stage4 |
7.790200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.794200E-01 |
| Normal-vs-AfricanAmerican |
6.745800E-01 |
| Normal-vs-Asian |
5.976000E-01 |
| Caucasian-vs-AfricanAmerican |
3.806600E-01 |
| Caucasian-vs-Asian |
6.049600E-01 |
| AfricanAmerican-vs-Asian |
3.647200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.772000E-01 |
| Normal-vs-Female |
5.377900E-02 |
| Male-vs-Female |
2.837600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.333600E-01 |
| Normal-vs-Extreme_Weight |
3.952800E-01 |
| Normal-vs-Obese |
6.809000E-01 |
| Normal-vs-Extreme_Obese |
5.548800E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.234600E-01 |
| Normal_Weight-vs-Obese |
2.476200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.511000E-01 |
| Extreme_Weight-vs-Obese |
2.897000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.955800E-01 |
| Obese-vs-Extreme_Obese |
5.910400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.002150E-02 |
| Normal-vs-Age(41-60Yrs) |
1.358820E-01 |
| Normal-vs-Age(61-80Yrs) |
6.339000E-01 |
| Normal-vs-Age(81-100Yrs) |
4.115000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.656400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.301940E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.9800999999955E-05 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.090400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.838660E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.509800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.514000E-01 |
| Normal-VS-Type2 PRCC |
6.103000E-01 |
| Normal-VS-KIRP CIMP |
1.754960E-01 |
| Normal-VS-Unclassified PRCC |
2.922200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.669610E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.507400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.669000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.274200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.144600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.561000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.591200E-01 |
| Normal-vs-N1 |
4.271400E-01 |
| Normal-vs-N2 |
1.955570E-01 |
| N0-vs-N1 |
1.758600E-01 |
| N0-vs-N2 |
6.777400E-01 |
| N1-vs-N2 |
3.763800E-01 |
|
|
